Zandelisib Terminated Phase 3 Trials for Marginal Zone Lymphoma (MZL) / Follicular Lymphoma ( FL) / Non-Hodgkin's Lymphoma (NHL) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04745832Phase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL)